INS and Hypoglycemia: In clinical analysis, insulin detemir declined hemoglobin A1C (Hb AIC) to a specific extent of 7.0% for 70% of subjects such as human basal insulin NPH, and may cause a low rate of hypoglycemia in patients with TIDM and TIIDM [52].